C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) G01N 33/53 (2006.01)
Patent
CA 2596845
The invention relates to method and compositions for treating and diagnosing cancer, in particular .beta.-catenin related cancers. In general, the methods include administering RNAi constructs. The invention further relates to methods of identifying CTNNBl related cancer therapeutics.
L'invention concerne un procédé et des compositions destinés à traiter et à diagnostiquer un cancer, plus particulièrement des cancers liés à la ß-caténine. De manière générale, ces procédés consistent à administrer des constructions d'ARNi. Cette invention concerne en outre des procédés d'identification de traitements liés au cancer CTNNB1.
Huppi Konrad
Roth Mark J.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Department Of Health And Human Services Government Of The United States Of America As Represented By The
Huppi Konrad
Roth Mark J.
LandOfFree
Diagnosing and treating cancer using .beta.-catenin splice... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnosing and treating cancer using .beta.-catenin splice..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnosing and treating cancer using .beta.-catenin splice... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1505713